While Charles River Laboratories International Inc has overperformed by 2.95%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CRL fell by -11.34%, with highs and lows ranging from $254.15 to $91.86, whereas the simple moving average fell by -1.28% in the last 200 days.
On July 09, 2025, Citigroup Upgraded Charles River Laboratories International Inc (NYSE: CRL) to Buy. A report published by Redburn Atlantic on May 23, 2025, Upgraded its rating to ‘Buy’ for CRL. TD Cowen also Upgraded CRL shares as ‘Buy’, setting a target price of $179 on the company’s shares in a report dated May 14, 2025. Goldman March 21, 2025d its ‘Buy’ rating to ‘Neutral’ for CRL, as published in its report on March 21, 2025. Citigroup’s report from March 04, 2025 suggests a price prediction of $175 for CRL shares, giving the stock a ‘Neutral’ rating. Redburn Atlantic also rated the stock as ‘Neutral’.
Analysis of Charles River Laboratories International Inc (CRL)
Further, the quarter-over-quarter decrease in sales is -2.71%, showing a negative trend in the upcoming months.
To gain a thorough understanding of Charles River Laboratories International Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -0.92% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.16, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and CRL is recording an average volume of 1.50M. On a monthly basis, the volatility of the stock is set at 3.35%, whereas on a weekly basis, it is put at 3.54%, with a gain of 3.92% over the past seven days. Furthermore, long-term investors anticipate a median target price of $157.21, showing decline from the present price of $163.66, which can serve as yet another indication of whether CRL is worth investing in or should be passed over.
How Do You Analyze Charles River Laboratories International Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.25%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 109.84% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CRL shares are owned by institutional investors to the tune of 109.84% at present.
